SavedAdd your journal

Journals / Journal of Basic and Clinical Health Sciences / 2021 / Cilt: 5 - Sayı: 3

Nutrition and Micronutrients in Cancer Patients Positive for COVID-19

Gamze Sanlav
Yasemin Basbinar
Mehmet Emin Arayici
Seda Yilmaz
Hamiyet Hekimci Ozdemir
Hulya Ellidokuz
Pages
233–239
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results might aid in the development of nutritional maintenance and complication control guidelines for all patients with cancer during the continuing COVID-19 pandemic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nutrition is an important component of human health that influences the immune response, especially in those who are at risk of cancer.
📊
Key Findings & Data:It is critical in the COVID-19 era to respond to cancer in a more coordinated and timely manner.
💡
Conclusion & Impact:The results might aid in the development of nutritional maintenance and complication control guidelines for all patients with cancer during the continuing COVID-19 pandemic.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:COVID-19 · Nutrition · Cancer

Abstract

Nutrition is an important component of human health that influences the immune response, especially in those who are at risk of cancer. It is critical in the COVID-19 era to respond to cancer in a more coordinated and timely manner. So far, there are only a few systematic studies on the increased prevalence of COVID-19 or SARS-CoV2 symptomatic or asymptomatic infections in cancer patients with no comprehensive care plan. The goal of this research is to learn more about the function of diet in cancer patients with in COVID-19 period. The importance of diet in the predisposition, prevention, and management of COVID-19 in cancer patients, as well as the role of dietary supplementation with vitamins or minerals, and microbiota in the COVID-19 period, was discussed in this study. The results might aid in the development of nutritional maintenance and complication control guidelines for all patients with cancer during the continuing COVID-19 pandemic.

🔖

Cite This Article

Sanlav, G., Basbinar, Y., Arayici, M. E., Yilmaz, S., Ozdemir, H. H., Ellidokuz, H. (2022). Nutrition and Micronutrients in Cancer Patients Positive for COVID-19. Journal of Basic and Clinical Health Sciences, Cilt: 5 - Sayı: 3, 233–239. https://ajindex.com/articles/560508

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. World Health Organization. 2020. http://www.emro.who.int/nutrition/news/nutrition-advice-for-adults-during-the-covid-19-outbreak.html
  2. Chen J, Lu H, Melino G, et al. COVID-19 infection: the China and Italy perspectives. Cell Death Dis. 2020;11(6):438. doi:10.1038/s41419-020-2603-0
  3. World Health Organization, Origin of SARS-CoV-2. 2020. (https://apps.who.int/iris/bitstream/handle/10665/332197/WHO-2019-nCoV-FAQ-Virus_origin-2020.1-eng.pdf)
  4. Tian J, Yuan X, Xiao J, et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. The Lancet. Oncology. 2020;21(7):893–903. https://doi.org/10.1016/S1470-2045(20)30309-0
  5. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet. Oncology. 2020;21(3):335–337. https://doi.org/10.1016/S1470-2045(20)30096-6
  6. Assi T, Ibrahim N, K Abboud RM, et al. The management of patients with metastatic prostate cancer during the COVID-19 pandemic. Future Oncology. 2020;16(20):1455–1461. https://doi.org/10.2217/fon-2020-0361
  7. Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Annals of oncology: official journal of the European Society for Medical Oncology. 2020;31(7):894–901. https://doi.org/10.1016/j.annonc.2020.03.296
  8. Carreira H, Strongman H, Peppa M, et al. Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: A matched cohort study using linked English electronic health records data, EClinicalMedicine. 2020;29-30:100656 https://doi.org/10.1016/j.eclinm.2020.100656
  9. Yigenoglu TN, Ata N, Altuntas F, et al. The outcome of COVID-19 in patients with hematological malignancy. Journal of medical virology. 2021;93(2):1099–1104. https://doi.org/10.1002/jmv.26404
  10. Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881–2892. https://doi.org/10.1182/blood.2020008824
  11. Lee LYW, Cazier JB, Starkey T, et al. UK Coronavirus Cancer Monitoring Project Team. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020;21(10):1309-1316. https://doi.org/10.1016/S1470-2045(20)30442-3.
  12. Tian J, Yuan X, Xi